Artificial intelligence has yet to deliver on the most challenging aspect of drug development -- finding new molecules that lead to ...

Artificial intelligence has yet to deliver on the most challenging aspect of drug development -- finding new molecules that lead to major medical advances -- but it is already streamlining less ...

Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.

To this day, animal testing remains one of the most controversial issues in animal rights. Activists have been fighting ...

Stability is a critical factor in drug formulation, with implications for product quality, lifecycle management, and ...

Real-time ¹⁹F NMR enables faster, more efficient pharmaceutical synthesis by improving reaction monitoring, scalability, and ...

A new study published in Therapeutic Innovation & Regulatory Science provides crucial insights into the design and ...

After J.P. Morgan, biotech’s bold promises meet real-world challenges. In 2026, success starts with a CDMO partner who ...

The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

Advances in biofabrication and 3D in vitro model systems are transforming biomedical research, drug development, and toxicity testing. However, despite ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...